BioXcel Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
47.64
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.35
|
-1.49
|
-0.14
|
-10.37%
|
|
2022-06-30
|
-1.22
|
-1.35
|
-0.13
|
-10.66%
|
|
2022-03-31
|
-1.15
|
-1.12
|
0.03
|
2.61%
|
|
2021-12-31
|
-1.10
|
-0.93
|
0.17
|
15.45%
|
|
2021-09-30
|
-1.05
|
-0.96
|
0.09
|
8.57%
|
|
2021-06-30
|
-1.08
|
-1.11
|
-0.03
|
-2.78%
|
|
2021-03-31
|
-0.94
|
-1.08
|
-0.14
|
-14.89%
|
|
2020-12-31
|
-0.96
|
-0.87
|
0.09
|
9.38%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.96
|
|
2021-12-31
|
-4.08
|
|
2020-12-31
|
-3.79
|
|
2019-12-31
|
-2.02
|
|
2018-12-31
|
-1.33
|
|
2017-12-31
|
-0.19
|